CAR-T Cell Preparation Systems for Niche Environments

Publication ID: 24-11857572_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “CAR-T Cell Preparation Systems for Niche Environments,” Published Technical Disclosure No. 24-11857572_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857572_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,572.

Summary of the Inventive Concept

This inventive concept discloses specialized systems and methods for preparing CAR-T cells with TCM as the main active component, tailored for specific, high-demand niches such as disaster relief, high-security environments, and extreme weather conditions.

Background and Problem Solved

The original patent disclosed a method for preparing CAR-T cells with TCM as the main active component. However, these methods were not adapted for use in specialized environments, limiting their applicability. This inventive concept addresses the need for CAR-T cell preparation systems that can operate effectively in remote, high-security, or extreme weather conditions.

Detailed Description of the Inventive Concept

The inventive concept encompasses a range of systems and methods for preparing CAR-T cells with TCM as the main active component. Specifically, it includes a portable and compact device for use in remote or disaster relief areas, designed to store and preserve TCM cells at controlled temperatures and humidity levels. It also includes methods for preparing CAR-T cells with tamper-evident mechanisms, additional markers for tracking and identification in high-security environments, and specialized containers for transportation and storage in extreme weather conditions. Furthermore, the inventive concept comprises modular and scalable devices for use in temporary or mobile medical facilities, with interchangeable components for adapting to different operational environments.

Novelty and Inventive Step

The inventive concept's novelty lies in its adaptation of CAR-T cell preparation systems for specific, high-demand niches. The inventive step resides in the combination of features such as portability, tamper-evidence, and environmental resistance, which enable the systems and methods to operate effectively in challenging environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different materials or designs for the portable device, alternative tamper-evident mechanisms, or variations in the specialized container's insulation and temperature control systems.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the fields of disaster relief, high-security environments, and extreme weather conditions. Target industries include emergency medical services, government agencies, and specialized medical facilities.

Field of Art

Immunotherapy, specifically CAR-T cell engineering and preparation techniques, with expertise in cell manipulation, immunological marker identification, and biomedical device design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or immunologist with advanced degree, familiar with CAR-T cell technologies, cell preservation techniques, and medical device engineering, capable of understanding complex cellular modification strategies

Obviousness Rationale

A PHOSITA would recognize that the PTD's variations represent predictable extensions of the source patent's core CAR-T cell technology, applying standard engineering principles to adapt the cellular preparation process for specialized environments. The disclosed modifications represent logical adaptations of existing CAR-T cell preparation methods to address practical deployment challenges. These variations demonstrate routine problem-solving within the field of cellular immunotherapy engineering.

Obvious Combinations & Variations

Source Patent Element
CAR-T cell preparation method using central memory T cells with artificial antigenic epitope
PTD Variation
Portable device for storing and preserving TCM cells at controlled temperature and humidity
Obviousness Reasoning
Predictable solution for cell preservation using known environmental control techniques, representing a standard engineering approach to maintaining cellular viability during transportation
Source Patent Element
CAR construct with extracellular domain modifications
PTD Variation
Additional tracking markers for high-security environment identification
Obviousness Reasoning
Known technique of adding molecular identifiers to cellular constructs, representing a routine modification for tracking and authentication purposes
Source Patent Element
T cell activation method using artificial antigenic epitope
PTD Variation
Modular device with interchangeable components for different operational environments
Obviousness Reasoning
Predictable design adaptation applying standard engineering modularity principles to medical device configuration
Source Patent Element
CAR-T cell preparation methodology
PTD Variation
Tamper-evident mechanisms for preventing unauthorized access or modification
Obviousness Reasoning
Routine security enhancement using standard biomedical engineering approaches to protect sensitive cellular preparations
Source Patent Element
Central memory T cell preparation technique
PTD Variation
Specialized container resistant to temperature and humidity variations
Obviousness Reasoning
Predictable solution using known materials science and engineering techniques to address environmental challenges in cellular preservation
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in the instant publication would have been obvious to a person having ordinary skill in the art at the time of invention, as they represent predictable extensions of the foundational techniques disclosed in US Patent 11857572, applying routine engineering problem-solving to CAR-T cell preparation and deployment challenges.

Original Patent Information

Patent NumberUS 11,857,572
TitleMethod for preparing CAR-T cell with TCM as main active component and use thereof
Assignee(s)Xuanwu Hospital Capital Medical University